Skip to main content
Earnings Labs
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI)

AMEX·Healthcare·Biotechnology

$0.14

-14.73%

Mkt Cap $2.62M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$5.50

Range $2.00$9.00

Implied Upside

+3716.8%

Consensus $5.50 vs current $0.14